You are here

Clinical Studies at the NIDCD (Intramural)

The NIDCD funds numerous clinical studies in the normal and disordered processes of hearing, balance, taste, smell, voice, speech, and language. Our intramural research program conducts clinical studies at the National Institutes of Health Clinical Center in Bethesda, Maryland. These studies are listed below.

Normal Values in Hearing and Balance Testing

Recruiting
Investigator
Category
Sponsor
Protocol
Clinical Trial ID
Hearing and balance
NIDCD
12-DC-0152
NCT01629108
Referral Contact
(301) 496 5294

Genetic Analyses of Nonsyndromic and Syndromic Deafness in Pakistan

Recruiting
Investigator
Category
Sponsor
Protocol
Clinical Trial ID
Hearing and balance
NIDCD
0H-93-DC-016
NCT00341874
Referral Contact
(301) 496 7882

A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal Cancer

Recruiting
Investigator
Category
Sponsor
Protocol
Clinical Trial ID
Head and neck cancer
NCI Collaborations
19-C-0130
NCT04044950
Referral Contact
(301) 402 6782

E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer

Recruiting
Investigator
Category
Sponsor
Protocol
Clinical Trial ID
Head and neck cancer
NCI Collaborations
19-C-0122
NCT04015336
Referral Contact
(301) 402 6782

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Recruiting
Investigator
Category
Sponsor
Protocol
Clinical Trial ID
Head and neck cancer
NCI Collaborations
16-C-0154
NCT02858310
Referral Contact
(301) 402 6782

M7824 in People with Recurrent Respiratory Papillomatosis

Active, not recruiting
Investigator
Category
Sponsor
Protocol
Clinical Trial ID
Recurrent respiratory papillomatosis
NCI Collaborations
19-C-0002
NCT03707587
Referral Contact
(301) 402 6782

Anti-PD-L1/TGF-beta Trap (M7824) Alone and in Combination With TriAd Vaccine and N-803 for Resectable Head and Neck Squamous Cell Carcinoma Not Associated With Human Papillomavirus Infection

Recruiting
Investigator
Category
Sponsor
Protocol
Clinical Trial ID
Head and neck cancer
NCI Collaborations
20-C-0024
NCT04247282
Referral Contact
(301) 402 6782

Birinapant and Intensity Modulated Re-Irradiation Therapy in Treating Patients With Locally Recurrent Head and Neck Squamous Cell Carcinoma

Recruiting
Investigator
Category
Sponsor
Protocol
Clinical Trial ID
Head and neck cancer
NCI Collaborations
19-C-0041
NCT03803774
Referral Contact
(301) 402 6782

Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies

Recruiting
Investigator
Category
Sponsor
Protocol
Clinical Trial ID
Head and neck cancer
NCI Collaborations
20-C-0045
NCT04287868
Referral Contact
(301) 402 6782

Biospecimen Procurement for NIDCD Clinical Protocols

Recruiting
Investigator
Category
Sponsor
Protocol
Clinical Trial ID
Head and neck cancer
NIDCD
18-DC-0051
NCT03429036
Referral Contact
(301) 402 6782

Patient Evaluation for Head and Neck Surgery Branch Studies

Recruiting
Investigator
Category
Sponsor
Protocol
Clinical Trial ID
Head and neck cancer
NIDCD
01-DC-0099
NCT00011492
Referral Contact
(301) 402 6782
Last Updated Date: 
July 22, 2020